Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. (2021)
Attributed to:
The impact of IFTIM3 genetic variation on Influenza virus infection, immune responses and disease outcome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00432-3
PubMed Identifier: 33617777
Publication URI: http://europepmc.org/abstract/MED/33617777
Type: Journal Article/Review
Volume: 397
Parent Publication: Lancet (London, England)
Issue: 10277
ISSN: 0140-6736